Figure 2
From: Relationship between subjective well-being and aripiprazole: an [11C]raclopride PET study

Diagram illustrating study protocol. (a) Aripiprazole; (b) positron emission tomography scan with [11C]raclopride; (c) plasma concentration of aripiprazole; (d) clinical assessments with Positive and Negative Syndrome scale, Korean version of subjective well-being under Neuroleptics Scale-Short form, Simpson-Angus Scale, Abnormal Involuntary Movement Scale, and Barnes Akathisia Rating Scale.